HIV Infections Clinical Trials

47 studies are recruiting for hiv infections in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies, page 2

1. SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Immigrant Families

   This study aims to prevent syndemic health conditions by decreasing acculturative stress and promoting resilience via SER Familia (Salud, Estrés y Resilencia en Familias/ Health, Stress, and Resilience in Families), a family-based intervention. SER Familia is a six-session intervention co-developed…

   Stage

   Not phased

   Ages

   12 to 100

   Site

   Duke School of Nursing, Durham, North Carolina

   Run by

   Duke University

   See if you can join NCT06627764 on ClinicalTrials.gov

2. Teamwork Makes the Dream Work

   Exploring the effect of team-based ARTAS intervention in an inpatient setting on HIV linkage to care and hospital readmission rates.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Loma Linda University Medical Center, Loma Linda, California

   Run by

   Loma Linda University

   See if you can join NCT05866523 on ClinicalTrials.gov

3. Comprehensive HIV and Harm Prevention Via Telehealth

   The purpose of this study is to test 2 different ways to offer medications to prevent human immunodeficiency virus (HIV), cure hepatitis C virus (HCV) (if applicable) and treat substance use disorder (if desired) in people who inject drugs.

   Stage

   Not phased

   Ages

   18 and older

   Site

   IDEA Miami, Miami, Florida

   Locations

   2 in total

   Run by

   University of Miami

   See if you can join NCT05897099 on ClinicalTrials.gov

4. Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)

   The purpose of this study is to test the effectiveness of the ACCESS strategy: an organizational-level intervention that uses funding and practice facilitation to improve the organizational capacity of syringe services programs (SSPs) to implement routine, opt-out HIV and Hepatitis C (HCV) testing …

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Miami, Miami, Florida

   Run by

   University of Miami

   See if you can join NCT06730555 on ClinicalTrials.gov

5. A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants

   This is an open-label, dose-escalation study to investigate the safety, tolerability and pharmacokinetics (PK) of single subcutaneous (SC) administration of long acting (LA) Cabotegravir (CAB) 200 milligrams per milliliter (mg/mL) with Recombinant Human Hyaluronidase PH20 (rHuPH20) (Part A), a sing…

   Stage

   Phase 1

   Ages

   18 to 55

   Site

   GSK Investigational Site, Las Vegas, Nevada

   Locations

   3 in total

   Run by

   ViiV Healthcare

   See if you can join NCT05418868 on ClinicalTrials.gov

6. Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

   This is a randomized placebo-controlled study in treated and suppressed HIV-infected individuals aged ≥40 years with either known CVD or 1 CVD risk factor to study the effect of Bempedoic acid (BA) on safety, arterial inflammation as assessed by FDG-PET/CT, lipids, inflammation, immune activation, …

   Stage

   Phase 2

   Ages

   40 and older

   Site

   UCLA Center for Clinical AIDS Research and Education (CARE), Los Angeles, California

   Locations

   3 in total

   Run by

   Priscilla Hsue, MD

   See if you can join NCT05488431 on ClinicalTrials.gov

7. Effect of High-Intensity Exercise to Attenuate Cognitive Function Limitations and Train Exercise Habits in Older People Living With HIV

   People aging with HIV are at higher risk for Alzheimer's disease and related dementias, and although physical activity is a promising target to mitigate such risk, this population engages in low levels of physical activity. Few studies have tested cognitive effects of exercise interventions or exam…

   Stage

   Not phased

   Ages

   50 to 80

   Site

   University of Colorado Denver, Aurora, Colorado

   Locations

   3 in total

   Run by

   University of Alabama at Birmingham

   See if you can join NCT06013579 on ClinicalTrials.gov

8. Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation

   The goal of this clinical trial is to evaluate the effectiveness of a social network intervention to recruit people who inject drugs and their networks for HIV testing and linkage to HIV prevention and treatment services in Maryland. Study aims are to determine the effectiveness of a social network…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Frederick County Health Department, Street Safe Program, Frederick, Maryland

   Locations

   2 in total

   Run by

   Johns Hopkins University

   See if you can join NCT06103370 on ClinicalTrials.gov

9. Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH)

   This randomized Type 1 hybrid effectiveness-implementation trial (N=186) will evaluate the effectiveness and implementation of a peer-delivered problem solving and behavioral activation intervention for adherence to LAI-PrEP/ART ("Peer Activate-LAI") compared to enhanced treatment as usual (ETAU) f…

   Stage

   Not phased

   Ages

   18 to 88

   Site

   HIPS (Harm reduction drop-in center), Washington D.C., District of Columbia

   Locations

   2 in total

   Run by

   University of Maryland, Baltimore

   See if you can join NCT06501781 on ClinicalTrials.gov

10. A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV

    The purpose of this study is to investigate safety, pharmacokinetics and tolerability following single ascending dose (SAD) and multiple ascending doses (MAD) of VH4011499 administered subcutaneously (SC) and intramuscularly (IM) in participants without HIV.

    Stage

    Phase 1

    Ages

    18 to 55

    Site

    GSK Investigational Site, Las Vegas, Nevada

    Locations

    2 in total

    Run by

    ViiV Healthcare

    See if you can join NCT06724640 on ClinicalTrials.gov

11. Exploring, Predicting, and Intervening on Long-term Viral Suppression Electronically

    Despite the widespread availability of effective antiretroviral therapy (ART) in the United States, there remains significant numbers of people living with HIV (PLWH) who fail to achieve and or maintain viral suppression (VS). Disparities persist with the lowest levels of VS among Black individuals…

    Stage

    Not phased

    Ages

    18 and older

    Site

    University of California, Los Angeles, Los Angeles, California

    Run by

    University of California, Los Angeles

    See if you can join NCT06370780 on ClinicalTrials.gov

12. HIV Treatment Adherence Dose Determination Trial

    The proposed research will conduct the first dose-determination trial to find the optimal number of behavioral counseling sessions (dose) needed to achieve and sustain optimal HIV treatment adherence. The results of this study will determine how much intervention is needed for whom and at what cost…

    Stage

    Not phased

    Ages

    18 and older

    Site

    University of Connecticut, Storrs, Connecticut

    Locations

    2 in total

    Run by

    University of Connecticut

    See if you can join NCT04577313 on ClinicalTrials.gov

13. Feasibility of HPV Testing With Mail-delivered Sample Collection Kits

    People living with human immunodeficiency virus (PLWH) have an estimated 1.6-6.0 times increased risk of developing oropharyngeal cancer (OPC) compared with individuals in the general population. 70% of OPCs are caused by human papillomavirus (HPV), and PLWH also have an increased prevalence of ora…

    Stage

    Not phased

    Ages

    35 and older

    Site

    University of California, San Francisco, San Francisco, California

    Run by

    University of California, San Francisco

    See if you can join NCT07087145 on ClinicalTrials.gov

14. Vaccine Immunity and Inflammation in the Aging Person Living With HIV

    This study will track immune responsiveness to conjugate pneumococcal vaccines over time to help determine how long protection from this vaccine lasts in individuals with chronic medical conditions (in this study - HIV) and with age.

    Stage

    Phase 4

    Ages

    18 and older

    Site

    Hennepin Healthcare System, Minneapolis, Minnesota

    Run by

    Hennepin Healthcare Research Institute

    See if you can join NCT06514547 on ClinicalTrials.gov

15. Screen Smart: Using Digital Health to Improve HIV Screening and Prevention

    The goal of this interrupted time series quasi-experimental design study is to implement universal opt- out HIV testing and linkage to HIV preventive care in 15-21 year old adolescents visiting the pediatric emergency department (ED). The main question[s] it aims to answer are: 1. What is the uptak…

    Stage

    Not phased

    Ages

    15 to 21

    Site

    Nationwide Children's Hospital, Columbus, Ohio

    Locations

    4 in total

    Run by

    Children's Hospital Medical Center, Cincinnati

    See if you can join NCT06003192 on ClinicalTrials.gov

16. Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.

    The purpose of the Antiretroviral Pregnancy Registry (Registry) is to detect any major teratogenic effect involving any of the Registry drugs when administered to pregnant people. Registration is voluntary and confidential with information obtained from the health care provider. A Registry-assigned…

    Stage

    Not phased

    Ages

    12 to 60

    Site

    Registry Coordinating Center, Wilmington, North Carolina

    Run by

    Syneos Health

    See if you can join NCT00404989 on ClinicalTrials.gov

17. TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk

    Ecological momentary interventions (EMI), which use phones to deliver messages to reduce alcohol use and related risk behaviors during or prior to drinking events, can help to address triggers in real-time. GPS tracking can determine when individuals visit places they have previously reported drink…

    Stage

    Not phased

    Ages

    18 to 35

    Site

    Yale University, New Haven, Connecticut

    Locations

    2 in total

    Run by

    University of Kentucky

    See if you can join NCT05576350 on ClinicalTrials.gov

18. Imaging Immune Activation in HIV by PET-MR

    This is a single center exploratory imaging study involving one intravenous microdose of [18F]F-AraG followed by whole-body positron emission tomography-magnetic resonance (PET-MR) imaging in HIV infected individuals to determine the anatomical distribution of the PET tracer. Participants will be e…

    Stage

    Phase 2

    Ages

    18 and older

    Site

    University of California, San Francisco, San Francisco, California

    Run by

    CellSight Technologies, Inc.

    See if you can join NCT03684655 on ClinicalTrials.gov

19. Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics

    The purpose of this study is to provide data on the pharmacokinetic (PK), safety, tolerability, efficacy and acceptability of this fixed dose combination (FDC) single tablet 2-drug regimen for virologically suppressed (HIV-1 RNA [Ribonucleic Acid] < 50 [cells per milliliter] c/mL) children 6 to les…

    Stage

    Phase 1

    Ages

    6 to 12

    Site

    GSK Investigational Site, Long Beach, California

    Locations

    8 in total

    Run by

    ViiV Healthcare

    See if you can join NCT05674656 on ClinicalTrials.gov

20. Alcohol Misuse, Gut Microbial Dysbiosis and PrEP Care Continuum: Application and Efficacy of SBIRT Intervention

    This randomized control trial study among Pre-exposure prophylactic users (PrEP) aims to learn and determine the efficacy of Screening, brief intervention, and referral to treatment (SBRIT) in reducing the risk of alcohol use. The main questions it aims to answer are: 1. How alcohol use impacts the…

    Stage

    Not phased

    Ages

    18 to 85

    Site

    University of Louisville, Louisville, Kentucky

    Run by

    Shirish S Barve

    See if you can join NCT06005298 on ClinicalTrials.gov

21. Keeping it LITE: Exploring HIV Risk in Vulnerable Youth With Limited Interaction and Digital Health Intervention

    Despite advances in HIV diagnostics, care and prevention strategies, infection rates among adolescent and young adult sexual and gender minorities (SGM) continue to rise in the United States (US). There is an urgent need to describe the epidemiology and trajectories of HIV acquisition in this popul…

    Stage

    Not phased

    Ages

    13 to 34

    Site

    John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois

    Run by

    Hektoen Institute for Medical Research

    See if you can join NCT05848570 on ClinicalTrials.gov

22. Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention

    The purpose of this study is to compare the effectiveness of two mobile health technologies (text messaging or a mobile app) designed to help people take HIV pre-exposure prophylaxis (PrEP) as directed by the clinic. PrEP is the use of a daily anti-HIV medications by HIV-negative people to help pre…

    Stage

    Not phased

    Ages

    15 and older

    Site

    San Francisco AIDS Foundation, San Francisco, California

    Locations

    4 in total

    Run by

    Public Health Foundation Enterprises, Inc.

    See if you can join NCT04855773 on ClinicalTrials.gov